Abstract
Despite the evidence of risks related to the use of anabolic steroids for the improvement of athletic performances, the diffusion of such drugs appears to be increasing. An exploratory study was conducted in Cagliari, Italy, to assess the level of information on this issue, to esteem the use of steroids among athletes, to measure the wellbeing of athletes and the risks related to steroid use. A sample of 192 athletes, including 142 non-agonists and 50 agonists (age range: 18 to 36) was invited to fill in a booklet including several selfreport questionnaires. The questionnaire for the assessment of the beliefs regarding the effects of anabolic steroids was developed and validated for the study, while the Self Reporting Questionnaire was used for the assessment of the mental health aspects. A general lack of information on the specific effects of steroid use on general and psychic health, as well as on sportive performances was found. Athletes were also quite unaware of the diffusion of steroids among them. Since the sportive environment seems to be the main source of information, this channel should be targeted to address the prevention and information campaigns. The use of more specific tools and the investigation of the perception of reliability of the information sources as well as the social desirability issues should be explored in future studies.
Keywords: Doping, androgenic anabolic steroids, mental health.
CNS & Neurological Disorders - Drug Targets
Title:What Do Athletes Know on the Effect of Steroids? An Exploratory Study in Italy
Volume: 14 Issue: 10
Author(s): Marcello Vellante, Maria Francesca Moro, Federica Sancassiani, Silvia Prost, Sergio Machado, Antonio Egidio Nardi, Antonio Preti and Gioia Mura
Affiliation:
Keywords: Doping, androgenic anabolic steroids, mental health.
Abstract: Despite the evidence of risks related to the use of anabolic steroids for the improvement of athletic performances, the diffusion of such drugs appears to be increasing. An exploratory study was conducted in Cagliari, Italy, to assess the level of information on this issue, to esteem the use of steroids among athletes, to measure the wellbeing of athletes and the risks related to steroid use. A sample of 192 athletes, including 142 non-agonists and 50 agonists (age range: 18 to 36) was invited to fill in a booklet including several selfreport questionnaires. The questionnaire for the assessment of the beliefs regarding the effects of anabolic steroids was developed and validated for the study, while the Self Reporting Questionnaire was used for the assessment of the mental health aspects. A general lack of information on the specific effects of steroid use on general and psychic health, as well as on sportive performances was found. Athletes were also quite unaware of the diffusion of steroids among them. Since the sportive environment seems to be the main source of information, this channel should be targeted to address the prevention and information campaigns. The use of more specific tools and the investigation of the perception of reliability of the information sources as well as the social desirability issues should be explored in future studies.
Export Options
About this article
Cite this article as:
Vellante Marcello, Francesca Moro Maria, Sancassiani Federica, Prost Silvia, Machado Sergio, Egidio Nardi Antonio, Preti Antonio and Mura Gioia, What Do Athletes Know on the Effect of Steroids? An Exploratory Study in Italy, CNS & Neurological Disorders - Drug Targets 2015; 14 (10) . https://dx.doi.org/10.2174/1871527315666151111122656
DOI https://dx.doi.org/10.2174/1871527315666151111122656 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Amyloid-Targeted Metal Chelation, Anti-Oxidative Stress, and Anti- Inflammation as Potential Alzheimers Therapies
Current Bioactive Compounds Editorial Thematic Issue: Targeting Synaptic Dysfunction and Neural Connectivity in Neurological and Psychiatric Disorders
Current Pharmaceutical Design Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response
Current Neuropharmacology Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids
Current Neuropharmacology Autism Spectrum Disorders: The Association with Inherited Metabolic Disorders and Some Trace Elements. A Retrospective Study
CNS & Neurological Disorders - Drug Targets Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
Current Pharmaceutical Design The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents
Current Cancer Therapy Reviews Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Role of Ca2+-Sensitive K+ Currents in Controlling Ventricular Repolarization: Possible Implications for Future Antiarrhytmic Drug Therapy
Current Medicinal Chemistry MoS<sub>2</sub>/Tio<sub>2</sub> Mixture: A Modification Strategies of Tio<sub>2</sub> Nanoparticles to Improve Photocatalytic Activity Under Visible Light
Current Environmental Management (Discontinued) Multifunctional Tacrine Derivatives in Alzheimer’s Disease
Current Topics in Medicinal Chemistry Male Contraception: An Overview of the Potential Target Events
Endocrine, Metabolic & Immune Disorders - Drug Targets Dimethyl Sulfoxide as an Excitatory Modulator and its Possible Role in Cancer Pain Management
Inflammation & Allergy - Drug Targets (Discontinued) Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen
CNS & Neurological Disorders - Drug Targets Remembrance and Historicization: The Transformation of Individual and Collective Trauma and its Transgenerational Consequences
Adolescent Psychiatry Nanomaterials for Neurology: State-of-the-Art
CNS & Neurological Disorders - Drug Targets The Oral and Intranasal Delivery of Propofol Using Chitosan Amphiphile Nanoparticles
Pharmaceutical Nanotechnology Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease
Current Pharmaceutical Design